Abstract
Age is the single most important prognostic factor associated with many cancers, including most leukemias and lymphomas. Aging is also associated with dramatic changes in hematopoiesis. As all mature hematopoietic cells are derived from multipotent hematopoietic stem cells (HSCs), age-dependent changes in these cells likely contribute to both alterations in hematopoiesis and increases in blood cancers. In this chapter, we will review the various changes in both HSCs and their microenvironments that could underlie the striking association between multiple major hematopoietic malignancies and old age. Traditionally, the association between aging and cancer has been explained by the requirement for sufficient time for the requisite number of oncogenic mutations to accumulate, as these mutations are thought to limit cancer incidence. We will describe how other aging-associated changes in hematopoietic stem/progenitor cells and their niches, including alterations in cellular fitness, inflammation, localization, and differentiation, could substantially impact age-dependent leukemogenesis. Aging of the hematopoietic system is highly complicated and multifactorial, and likewise increased leukemogenesis in the elderly will likely belie simple explanations.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Agrawal N et al (2012) Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma. Cancer Discov 2(10):899–905
Alizadeh AA, Majeti R (2011) Surprise! HSC are aberrant in chronic lymphocytic leukemia. Cancer Cell 20(2):135–136
Allman D, Miller JP (2005) The aging of early B-cell precursors. Immunol Rev 205:18–29
Almog N et al (2006) Prolonged dormancy of human liposarcoma is associated with impaired tumor angiogenesis. FASEB J 20(7):947–949
Andrew D, Aspinall R (2001) Il-7 and not stem cell factor reverses both the increase in apoptosis and the decline in thymopoiesis seen in aged mice. J Immunol 166(3):1524–1530
Anisimov VN (2009) Carcinogenesis and aging 20 years after: escaping horizon. Mech Ageing Dev 130(1–2):105–121
Armstrong SA et al (2004) FLT3 mutations in childhood acute lymphoblastic leukemia. Blood 103(9):3544–3546
Aspinall R, Andrew D (2000a) Thymic atrophy in the mouse is a soluble problem of the thymic environment. Vaccine 18(16):1629–1637
Aspinall R, Andrew D (2000b) Thymic involution in aging. J Clin Immunol 20(4):250–256
Bagby GC, Meyers G (2009) Myelodysplasia and acute leukemia as late complications of marrow failure: future prospects for leukemia prevention. Hematol Oncol Clin North Am 23(2):361–376
Baldridge MT et al (2010) Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection. Nature 465(7299):793–797
Balducci L, Beghe C (2001) Cancer and age in the USA. Crit Rev Oncol Hematol 37(2):137–145
Beerman I et al (2010a) Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion. Proc Natl Acad Sci U S A 107(12):5465–5470
Beerman I et al (2010b) Stem cells and the aging hematopoietic system. Curr Opin Immunol 22(4):500–506
Bell JT, Spector TD (2011) A twin approach to unraveling epigenetics. Trends Genet 27(3):116–125
Benz CC, Yau C (2008) Ageing, oxidative stress and cancer: paradigms in parallax. Nat Rev Cancer 8(11):875–879
Biernaux C et al (1995) Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals. Blood 86(8):3118–3122
Blagosklonny MV (2002) Oncogenic resistance to growth-limiting conditions. Nat Rev Cancer 2(3):221–225
Blagosklonny MV (2008) Prevention of cancer by inhibiting aging. Cancer Biol Ther 7(10):1520–1524
Blagosklonny MV et al (2010) Impact papers on aging in 2009. Aging (Albany NY) 2(3):111–121
Bose S et al (1998) The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: biologic significance and implications for the assessment of minimal residual disease. Blood 92(9):3362–3367
Bowie MB et al (2006) Hematopoietic stem cells proliferate until after birth and show a reversible phase-specific engraftment defect. J Clin Invest 116(10):2808–2816
Cain D et al (2009) Effects of acute and chronic inflammation on B-cell development and differentiation. J Invest Dermatol 129(2):266–277
Campisi J (2005a) Suppressing cancer: the importance of being senescent. Science 309(5736):886–887
Campisi J (2005b) Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120(4):513–522
Carlson LM et al (2013) Low-dose aspirin delays an inflammatory tumor progression in vivo in a transgenic mouse model of neuroblastoma. Carcinogenesis 34(5):1081–1088
Casas-Selves M, DeGregori J (2011) How cancer shapes evolution, and how evolution shapes cancer. Evol Educ Outreach 4:624–634
Challen GA et al (2010) Distinct hematopoietic stem cell subtypes are differentially regulated by TGF-beta1. Cell Stem Cell 6(3):265–278
Chambers SM, Goodell MA (2007) Hematopoietic stem cell aging: wrinkles in stem cell potential. Stem Cell Rev 3(3):201–211
Chambers SM et al (2007) Aging hematopoietic stem cells decline in function and exhibit epigenetic dysregulation. PLoS Biol 5(8), e201
Chang S, Khoo C, DePinho RA (2001) Modeling chromosomal instability and epithelial carcinogenesis in the telomerase-deficient mouse. Semin Cancer Biol 11(3):227–239
Chen J, Astle CM, Harrison DE (1999) Development and aging of primitive hematopoietic stem cells in BALB/cBy mice. Exp Hematol 27(5):928–935
Chen J, Astle CM, Harrison DE (2000) Genetic regulation of primitive hematopoietic stem cell senescence. Exp Hematol 28(4):442–450
Chiorazzi N, Rai KR, Ferrarini M (2005) Chronic lymphocytic leukemia. N Engl J Med 352(8):804–815
Cho RH, Sieburg HB, Muller-Sieburg CE (2008) A new mechanism for the aging of hematopoietic stem cells: aging changes the clonal composition of the stem cell compartment but not individual stem cells. Blood 111(12):5553–5561
Crawford YG et al (2004) Histologically normal human mammary epithelia with silenced p16(INK4a) overexpress COX-2, promoting a premalignant program. Cancer Cell 5(3):263–273
Damm F et al (2014) Acquired initiating mutations in early hematopoietic cells of CLL patients. Cancer Discov 4(9):1088–1101
de Haan G, Van Zant G (1999) Dynamic changes in mouse hematopoietic stem cell numbers during aging. Blood 93(10):3294–3301
DeGregori J (2011) Evolved tumor suppression: why are we so good at not getting cancer? Cancer Res 71(11):3739–3744
DeGregori J (2013) Challenging the axiom: does the occurrence of oncogenic mutations truly limit cancer development with age? Oncogene 32(15):1869–1875
DePinho RA (2000) The age of cancer. Nature 408(6809):248–254
Dorshkind K, Swain S (2009) Age-associated declines in immune system development and function: causes, consequences, and reversal. Curr Opin Immunol 21(4):404–407
Dorshkind K, Montecino-Rodriguez E, Signer RA (2009) The ageing immune system: is it ever too old to become young again? Nat Rev Immunol 9(1):57–62
Dykstra B et al (2011) Clonal analysis reveals multiple functional defects of aged murine hematopoietic stem cells. J Exp Med 208(13):2691–2703
Edwards BK et al (2002) Annual report to the nation on the status of cancer, 1973–1999, featuring implications of age and aging on U.S. cancer burden. Cancer 94(10):2766–2792
Eliasson P et al (2010) Hypoxia mediates low cell-cycle activity and increases the proportion of long-term-reconstituting hematopoietic stem cells during in vitro culture. Exp Hematol 38(4):301–310. e2
Essers MA et al (2009) IFNalpha activates dormant haematopoietic stem cells in vivo. Nature 458(7240):904–908
Finkel T, Serrano M, Blasco MA (2007) The common biology of cancer and ageing. Nature 448(7155):767–774
Flach J et al (2014) Replication stress is a potent driver of functional decline in ageing haematopoietic stem cells. Nature 512(7513):198–202, Advance online publication
Fleenor CJ, Marusyk A, DeGregori J (2010) Ionizing radiation and hematopoietic malignancies: altering the adaptive landscape. Cell Cycle 9(15):3005–3011
Florian MC et al (2012) Cdc42 activity regulates hematopoietic stem cell aging and rejuvenation. Cell Stem Cell 10(5):520–530
Florian MC et al (2013) A canonical to non-canonical Wnt signalling switch in haematopoietic stem-cell ageing. Nature 503(7476):392–396
Franceschi C et al (2000) Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 908:244–254
Franceschi C et al (2005) Genes involved in immune response/inflammation, IGF1/insulin pathway and response to oxidative stress play a major role in the genetics of human longevity: the lesson of centenarians. Mech Ageing Dev 126(2):351–361
Frank SA (2010) Evolution in health and medicine Sackler colloquium: somatic evolutionary genomics: mutations during development cause highly variable genetic mosaicism with risk of cancer and neurodegeneration. Proc Natl Acad Sci U S A 107 Suppl 1:1725–1730
Frasca D et al (2012) A molecular mechanism for TNF-alpha-mediated downregulation of B cell responses. J Immunol 188(1):279–286
Gaidano G, Foa R, Dalla-Favera R (2012) Molecular pathogenesis of chronic lymphocytic leukemia. J Clin Invest 122(10):3432–3438
Garaycoechea JI et al (2012) Genotoxic consequences of endogenous aldehydes on mouse haematopoietic stem cell function. Nature 489(7417):571–575
Garcia-Manero G et al (2003) Chronic myelogenous leukemia: a review and update of therapeutic strategies. Cancer 98(3):437–457
Garinis GA et al (2008) DNA damage and ageing: new-age ideas for an age-old problem. Nat Cell Biol 10(11):1241–1247
Gatenby RA, Gillies RJ (2008) A microenvironmental model of carcinogenesis. Nat Rev Cancer 8(1):56–61
Goto M (2008) Inflammaging (inflammation + aging): a driving force for human aging based on an evolutionarily antagonistic pleiotropy theory? Biosci Trends 2(6):218–230
Greaves M, Maley CC (2012) Clonal evolution in cancer. Nature 481(7381):306–313
Greaves MF, Wiemels J (2003) Origins of chromosome translocations in childhood leukaemia. Nat Rev Cancer 3(9):639–649
Guerrettaz LM, Johnson SA, Cambier JC (2008) Acquired hematopoietic stem cell defects determine B-cell repertoire changes associated with aging. Proc Natl Acad Sci U S A 105(33):11898–11902
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674
Hao Y et al (2011) A B-cell subset uniquely responsive to innate stimuli accumulates in aged mice. Blood 118(5):1294–1304
Henry CJ et al (2010) Declining lymphoid progenitor fitness promotes aging-associated leukemogenesis. Proc Natl Acad Sci U S A 107(50):21713–21718
Henry CJ, Marusyk A, DeGregori J (2011) Aging-associated changes in hematopoiesis and leukemogenesis: what’s the connection? Aging (Albany NY) 3(6):643–656
Hindley C, Philpott A (2012) Co-ordination of cell cycle and differentiation in the developing nervous system. Biochem J 444(3):375–382
Hinkal G, Parikh N, Donehower LA (2009a) Timed somatic deletion of p53 in mice reveals age-associated differences in tumor progression. PLoS One 4(8), e6654
Hinkal GW et al (2009b) Altered senescence, apoptosis, and DNA damage response in a mutant p53 model of accelerated aging. Mech Ageing Dev 130(4):262–271
Hoeijmakers JH (2009) DNA damage, aging, and cancer. N Engl J Med 361(15):1475–1485
Horvath S (2013) DNA methylation age of human tissues and cell types. Genome Biol 14(10):R115
Jaskelioff M et al (2011) Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice. Nature 469(7328):102–106
Karin M, Greten FR (2005) NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5(10):749–759
Karin M, Lawrence T, Nizet V (2006) Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 124(4):823–835
Kelly LM, Gilliland DG (2002) Genetics of myeloid leukemias. Annu Rev Genomics Hum Genet 3:179–198
Kennedy SR, Loeb LA, Herr AJ (2012) Somatic mutations in aging, cancer and neurodegeneration. Mech Ageing Dev 133(4):118–126
Kent DG et al (2009) Prospective isolation and molecular characterization of hematopoietic stem cells with durable self-renewal potential. Blood 113(25):6342–6350
Keren Z et al (2011a) Chronic B cell deficiency from birth prevents age-related alterations in the B lineage. J Immunol 187(5):2140–2147
Keren Z et al (2011b) B-cell depletion reactivates B lymphopoiesis in the BM and rejuvenates the B lineage in aging. Blood 117(11):3104–3112
Kikushige Y et al (2011) Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia. Cancer Cell 20(2):246–259
King KY, Goodell MA (2011) Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response. Nat Rev Immunol 11(10):685–692
Kirkwood TB (2005) Understanding the odd science of aging. Cell 120(4):437–447
Kohler A et al (2009) Altered cellular dynamics and endosteal location of aged early hematopoietic progenitor cells revealed by time-lapse intravital imaging in long bones. Blood 114(2):290–298
Kollman C et al (2001) Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood 98(7):2043–2051
Kristinsson SY et al (2011) Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes. J Clin Oncol 29(21):2897–2903
Kuranda K et al (2011) Age-related changes in human hematopoietic stem/progenitor cells. Aging Cell 10(3):542–546
Laconi E, Doratiotto S, Vineis P (2008) The microenvironments of multistage carcinogenesis. Semin Cancer Biol 18:322–329
Lescale C et al (2010) Reduced EBF expression underlies loss of B cell potential of hematopoietic progenitors with age. Aging Cell 9(3):410–419
Liang Y, Van Zant G, Szilvassy SJ (2005) Effects of aging on the homing and engraftment of murine hematopoietic stem and progenitor cells. Blood 106(4):1479–1487
Linton PJ, Dorshkind K (2004) Age-related changes in lymphocyte development and function. Nat Immunol 5(2):133–139
Losman JA et al (2013) (R)-2-hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversible. Science 339(6127):1621–1625
Lowenberg B, Downing JR, Burnett A (1999) Acute myeloid leukemia. N Engl J Med 341(14):1051–1062
Lynch M (1988) The rate of polygenic mutation. Genet Res 51(2):137–148
Lynch M (2010a) Evolution of the mutation rate. Trends Genet 26(8):345–352
Lynch M (2010b) Rate, molecular spectrum, and consequences of human mutation. Proc Natl Acad Sci U S A 107(3):961–968
Malfertheiner P, Schutte K (2006) Smoking–a trigger for chronic inflammation and cancer development in the pancreas. Am J Gastroenterol 101(1):160–162
Marusyk A, DeGregori J (2008) Declining cellular fitness with age promotes cancer initiation by selecting for adaptive oncogenic mutations. Biochim Biophys Acta 1785(1):1–11
Matioli GT (2002) BCR-ABL insufficiency for the transformation of human stem cells into CML. Med Hypotheses 59(5):588–589
Medawar P (1952) An unsolved problem of biology. H.K. Lewis, London
Miller JP, Allman D (2003) The decline in B lymphopoiesis in aged mice reflects loss of very early B-lineage precursors. J Immunol 171(5):2326–2330
Miller JP, Allman D (2005) Linking age-related defects in B lymphopoiesis to the aging of hematopoietic stem cells. Semin Immunol 17(5):321–329
Milne CD, Paige CJ (2006) IL-7: a key regulator of B lymphopoiesis. Semin Immunol 18(1):20–30
Mirantes C, Passegue E, Pietras EM (2014) Pro-inflammatory cytokines: emerging players regulating HSC function in normal and diseased hematopoiesis. Exp Cell Res 329(2):248–254
Morrison SJ et al (1996) The aging of hematopoietic stem cells. Nat Med 2(9):1011–1016
Muller-Sieburg CE et al (2004) Myeloid-biased hematopoietic stem cells have extensive self-renewal capacity but generate diminished lymphoid progeny with impaired IL-7 responsiveness. Blood 103(11):4111–4118
Mullighan CG et al (2008) BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature 453(7191):110–114
Mutter GL et al (2001) Molecular identification of latent precancers in histologically normal endometrium. Cancer Res 61(11):4311–4314
Naumov GN, Akslen LA, Folkman J (2006a) Role of angiogenesis in human tumor dormancy: animal models of the angiogenic switch. Cell Cycle 5(16):1779–1787
Naumov GN et al (2006b) A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype. J Natl Cancer Inst 98(5):316–325
Noda S, Ichikawa H, Miyoshi H (2009) Hematopoietic stem cell aging is associated with functional decline and delayed cell cycle progression. Biochem Biophys Res Commun 383(2):210–215
Nowell PC (1976) The clonal evolution of tumor cell populations. Science 194(4260):23–28
Omatsu Y et al (2010) The essential functions of adipo-osteogenic progenitors as the hematopoietic stem and progenitor cell niche. Immunity 33(3):387–399
Pang WW et al (2011) Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age. Proc Natl Acad Sci U S A 108(50):20012–20017
Peto R et al (1975) Cancer and ageing in mice and men. Br J Cancer 32(4):411–426
Pietras EM, Warr MR, Passegue E (2011) Cell cycle regulation in hematopoietic stem cells. J Cell Biol 195(5):709–720
Pietras EM et al (2014) Re-entry into quiescence protects hematopoietic stem cells from the killing effect of chronic exposure to type I interferons. J Exp Med 211(2):245–262
Prensner JR, Chinnaiyan AM (2011) Metabolism unhinged: IDH mutations in cancer. Nat Med 17(3):291–293
Prieyl JA, LeBien TW (1996) Interleukin 7 independent development of human B cells. Proc Natl Acad Sci U S A 93(19):10348–10353
Pronk CJ et al (2011) Tumor necrosis factor restricts hematopoietic stem cell activity in mice: involvement of two distinct receptors. J Exp Med 208(8):1563–1570
Puente XS et al (2011) Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 475(7354):101–105
Quesada V et al (2011) Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet 44(1):47–52
Randolph TR (2005) Chronic myelocytic leukemia–part I: history, clinical presentation, and molecular biology. Clin Lab Sci 18(1):38–48
Ratliff M et al (2010) In senescence, age-associated B cells secrete TNFalpha and inhibit survival of B-cell precursors. Aging Cell 12(2):303–311
Rawlings DJ et al (1995) Long-term culture system for selective growth of human B-cell progenitors. Proc Natl Acad Sci U S A 92(5):1570–1574
Renehan AG, Roberts DL, Dive C (2008) Obesity and cancer: pathophysiological and biological mechanisms. Arch Physiol Biochem 114(1):71–83
Roberts DL, Dive C, Renehan AG (2010) Biological mechanisms linking obesity and cancer risk: new perspectives. Annu Rev Med 61:301–316
Rossi DJ et al (2005) Cell intrinsic alterations underlie hematopoietic stem cell aging. Proc Natl Acad Sci U S A 102(26):9194–9199
Rossi DJ et al (2007a) Hematopoietic stem cell quiescence attenuates DNA damage response and permits DNA damage accumulation during aging. Cell Cycle 6(19):2371–2376
Rossi DJ et al (2007b) Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature 447(7145):725–729
Rozhok AI, Salstrom JL, DeGregori J (2014) Stochastic modeling indicates that aging and somatic evolution in the hematopoietic system are driven by non-cell-autonomous processes. Aging (Albany NY) 6(12):1033–1048
Rubtsov AV et al (2011) Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c(+) B-cell population is important for the development of autoimmunity. Blood 118(5):1305–1315
Rubtsov AV et al (2013) TLR7 drives accumulation of ABCs and autoantibody production in autoimmune-prone mice. Immunol Res 55(1–3):210–216
Rufer N et al (1999) Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood. J Exp Med 190(2):157–167
Sahin E, Depinho RA (2010) Linking functional decline of telomeres, mitochondria and stem cells during ageing. Nature 464(7288):520–528
Salvioli S et al (2009) Why do centenarians escape or postpone cancer? The role of IGF-1, inflammation and p53. Cancer Immunol Immunother 58(12):1909–1917
Sanders MA, Valk PJ (2013) The evolving molecular genetic landscape in acute myeloid leukaemia. Curr Opin Hematol 20(2):79–85
Sawyers CL (1999) Chronic myeloid leukemia. N Engl J Med 340(17):1330–1340
Serrano M, Blasco MA (2007) Cancer and ageing: convergent and divergent mechanisms. Nat Rev Mol Cell Biol 8(9):715–722
Sharpless NE, DePinho RA (2002) p53: good cop/bad cop. Cell 110(1):9–12
Sharpless NE, DePinho RA (2004) Telomeres, stem cells, senescence, and cancer. J Clin Invest 113(2):160–168
Sharpless NE, DePinho RA (2007) How stem cells age and why this makes us grow old. Nat Rev Mol Cell Biol 8(9):703–713
Shaw AC et al (2010) Aging of the innate immune system. Curr Opin Immunol 22(4):507–513
Signer RA et al (2007) Age-related defects in B lymphopoiesis underlie the myeloid dominance of adult leukemia. Blood 110(6):1831–1839
Signer RA et al (2008) Aging and cancer resistance in lymphoid progenitors are linked processes conferred by p16Ink4a and Arf. Genes Dev 22(22):3115–3120
Silander OK, Tenaillon O, Chao L (2007) Understanding the evolutionary fate of finite populations: the dynamics of mutational effects. PLoS Biol 5(4), e94
Simsek T et al (2010) The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche. Cell Stem Cell 7(3):380–390
Small D (2006) FLT3 mutations: biology and treatment. Hematology Am Soc Hematol Educ Program 178–184
Song Z et al (2010) Alterations of the systemic environment are the primary cause of impaired B and T lymphopoiesis in telomere-dysfunctional mice. Blood 115(8):1481–1489
Steinman RA (2002) Cell cycle regulators and hematopoiesis. Oncogene 21(21):3403–3413
Stephan RP, Reilly CR, Witte PL (1998) Impaired ability of bone marrow stromal cells to support B-lymphopoiesis with age. Blood 91(1):75–88
Sudo K et al (2000) Age-associated characteristics of murine hematopoietic stem cells. J Exp Med 192(9):1273–1280
Sun D et al (2014) Epigenomic profiling of young and aged HSCs reveals concerted changes during aging that reinforce self-renewal. Cell Stem Cell 14(5):673–688
Takubo K et al (2010) Regulation of the HIF-1alpha level is essential for hematopoietic stem cells. Cell Stem Cell 7(3):391–402
Thakkar A et al (2013) The molecular mechanism of action of aspirin, curcumin and sulforaphane combinations in the chemoprevention of pancreatic cancer. Oncol Rep 29(4):1671–1677
Ueda Y et al (2004) Inflammation controls B lymphopoiesis by regulating chemokine CXCL12 expression. J Exp Med 199(1):47–58
Ueda Y, Kondo M, Kelsoe G (2005) Inflammation and the reciprocal production of granulocytes and lymphocytes in bone marrow. J Exp Med 201(11):1771–1780
Van Zant G et al (1990) Genotype-restricted growth and aging patterns in hematopoietic stem cell populations of allophenic mice. J Exp Med 171(5):1547–1565
Vaziri H et al (1994) Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci U S A 91(21):9857–9860
Vickers M (1996) Estimation of the number of mutations necessary to cause chronic myeloid leukaemia from epidemiological data. Br J Haematol 94(1):1–4
Vijg J et al (2005) Aging and genome maintenance. Ann N Y Acad Sci 1055:35–47
Vogelstein B, Kinzler KW (2004) Cancer genes and the pathways they control. Nat Med 10(8):789–799
Wahlestedt M et al (2013) An epigenetic component of hematopoietic stem cell aging amenable to reprogramming into a young state. Blood 121(21):4257–4264
Warr MR et al (2013) FOXO3A directs a protective autophagy program in haematopoietic stem cells. Nature 494(7437):323–327
Warren LA, Rossi DJ (2009) Stem cells and aging in the hematopoietic system. Mech Ageing Dev 130(1–2):46–53
Weinberg R (2007) The biology of cancer (Chapter 11). Garland Science, New York
Weinberger B et al (2008) Biology of immune responses to vaccines in elderly persons. Clin Infect Dis 46(7):1078–1084
Weiskopf D, Weinberger B, Grubeck-Loebenstein B (2009) The aging of the immune system. Transpl Int 22(11):1041–1050
Weksler ME, Szabo P (2000) The effect of age on the B-cell repertoire. J Clin Immunol 20(4):240–249
Weksler ME, Goodhardt M, Szabo P (2002) The effect of age on B cell development and humoral immunity. Springer Semin Immunopathol 24(1):35–52
Weng NP, Hathcock KS, Hodes RJ (1998) Regulation of telomere length and telomerase in T and B cells: a mechanism for maintaining replicative potential. Immunity 9(2):151–157
Williams GC (1957) Pleiotropy, natural selection, and the evolution of senescence. Evolution 11:398–411
Wilson A et al (2008) Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell 135(6):1118–1129
Wynford-Thomas D et al (1995) Does telomere shortening drive selection for p53 mutation in human cancer? Mol Carcinog 12(3):119–123
Xing Z et al (2006) Increased hematopoietic stem cell mobilization in aged mice. Blood 108(7):2190–2197
Yamazaki S et al (2009) TGF-beta as a candidate bone marrow niche signal to induce hematopoietic stem cell hibernation. Blood 113(6):1250–1256
Yin T, Li L (2010) Fountain of Youth: aged blood-forming stem cells could be rejuvenated by young microenvironment. Cell Res 20(5):504–505
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Wien
About this chapter
Cite this chapter
Henry, C.J., Rozhok, A.I., DeGregori, J. (2015). Hematopoietic Stem Cell Aging and Leukemogenesis. In: Geiger, H., Jasper, H., Florian, M. (eds) Stem Cell Aging: Mechanisms, Consequences, Rejuvenation. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1232-8_13
Download citation
DOI: https://doi.org/10.1007/978-3-7091-1232-8_13
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-1231-1
Online ISBN: 978-3-7091-1232-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)